Grossman Adam S's Form 4 filing
Adma Biologics, Inc.ADMA · filed Aug 17, 2023
- Accession no.
- 0001140361-23-040322
- Filed
- Aug 17, 2023
- Trade date
- Aug 15-16, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 9 non-derivative transactions and 6 derivative transactions. Open-market sales total $2.32M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Grossman Adam SCIK 0001542517 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2023 | Common Stock | MOption exerciseAcquired | +212,500 | $1.67 | +$354,875 | 2,735,585 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseAcquired | +277,131 | $2.35 | +$651,257.85 | 3,012,716 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseAcquired | +277,604 | $2.92 | +$810,603.68 | 3,290,320 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseAcquired | +400,000 | $3.22 | +$1,288,000 | 3,690,320 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseAcquired | +350,000 | $3.71 | +$1,298,500 | 4,040,320 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseAcquired | +583,224 | $3.66 | +$2,134,599.84 | 4,623,544 | Direct | |
| Aug 15, 2023 | Common Stock | SSaleDisposed | −510,469 | $4.54F1 | −$2,317,529.26 | 4,113,075 | Direct | |
| Aug 15, 2023 | Common Stock | FTax withholdingDisposed | −1,589,987 | $4.61 | −$7,329,840.07 | 2,523,088 | Direct | |
| Aug 16, 2023 | Common Stock | SSaleDisposed | −3 | $4.39 | −$13.17 | 2,523,085 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 15, 2023 | Common Stock | MOption exerciseDisposed | −212,500 | $1.67 | −$354,875 | 387,500 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseDisposed | −277,131 | $2.35 | −$651,257.85 | 181,569 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseDisposed | −277,604 | $2.92 | −$810,603.68 | 47,396 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseDisposed | −400,000 | $3.22 | −$1,288,000 | 0 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseDisposed | −350,000 | $3.71 | −$1,298,500 | 0 | Direct | |
| Aug 15, 2023 | Common Stock | MOption exerciseDisposed | −583,224 | $3.66 | −$2,134,599.84 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Reflects the weighted average price of sales on August 15, 2023. The shares were sold in multiple transactions at prices ranging from $4.495 to $4.63, inclusive.
Referenced by the price of 1 transaction in Table I.